Stefania Orlando

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Cerebrospinal Fluid

Multiple Sclerosis

Top Venues

International journal of molecular sciences

Pharmaceuticals (Basel, Switzerland)

Healthcare (Basel, Switzerland)

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Roberto De Masi, Stefania Orlando, Elisabetta Carata, Elisa Panzarini
Ultrastructural Characterization of PBMCs and Extracellular Vesicles in Multiple Sclerosis: A Pilot Study. International journal of molecular sciences 25 (13) (2024)
Roberto De Masi, Stefania Orlando, Elisabetta Carata, Elisa Panzarini
Ultrastructural Characterization of PBMCs and Extracellular Vesicles in Multiple Sclerosis: A Pilot Study. International journal of molecular sciences 25 (13) (2024)
Roberto De Masi, Stefania Orlando, Vincenzo Toni, Maria Carmela Costa
Fluphenazine-Induced Neurotoxicity with Acute Almost Transient Parkinsonism and Permanent Memory Loss: Lessons from a Case Report. International journal of molecular sciences 24 (3) (2023)
Roberto De Masi, Stefania Orlando, Vincenzo Toni, Maria Carmela Costa
Fluphenazine-Induced Neurotoxicity with Acute Almost Transient Parkinsonism and Permanent Memory Loss: Lessons from a Case Report. International journal of molecular sciences 24 (3) (2023)
Roberto De Masi, Stefania Orlando, Vincenzo Toni, Maria Carmela Costa
Fluphenazine-Induced Neurotoxicity with Acute Almost Transient Parkinsonism and Permanent Memory Loss: Lessons from a Case Report. International journal of molecular sciences 24 (3) (2023)
Roberto De Masi, Stefania Orlando, Chiara Leo, Matteo Pasca, Luca Anzilli, Maria Carmela Costa
Multi-Criterial Model for Weighting Biological Risk Factors in Multiple Sclerosis: Clinical and Health Insurance Implications. Healthcare (Basel, Switzerland) 11 (17) (2023)
Roberto De Masi, Stefania Orlando, Maria Carmela Costa
Dementia-Associated Compulsive Singing (DACS): Presentation of Unpublished Clinical Cases Miniseries. International journal of environmental research and public health 19 (17) (2022)
Roberto De Masi, Stefania Orlando
GANAB and N -Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review. International journal of molecular sciences 23 (13) (2022)
Roberto De Masi, Stefania Orlando, Silvia Armenise, Pantaleo Spagnolo, Ruggero Capra, Maria Carmela Costa
Changes in Brain Volumes Are Relevant during Natalizumab-Associated Progressive Multifocal Leukoencephalopathy: Lessons from a Case Report. International journal of molecular sciences 23 (21) (2022)
Roberto De Masi, Stefania Orlando, Antonella De Donno
The Age-Related Efficacy of Dimethyl Fumarate and Natalizumab in the Real-World Management of Multiple Sclerosis. Pharmaceuticals (Basel, Switzerland) 14 (2) (2021)
Roberto De Masi, Stefania Orlando, Francesco Bagordo, Tiziana Grassi
IFP35 Is a Relevant Factor in Innate Immunity, Multiple Sclerosis, and Other Chronic Inflammatory Diseases: A Review. Biology 10 (12) (2021)
Roberto De Masi, Stefania Orlando
GANAB as a Novel Biomarker in Multiple Sclerosis: Correlation with Neuroinflammation and IFI35. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)